Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.0400
+0.0186 (86.92%)
Jul 9, 2026, 12:32 PM EST
RMTG Revenue
Regenerative Medical Technology Group had revenue of $2.64M in the quarter ending March 31, 2026, with 93.45% growth. This brings the company's revenue in the last twelve months to $6.38M, up 36.96% year-over-year. In the year 2025, Regenerative Medical Technology Group had annual revenue of $5.10M with 24.17% growth.
Revenue (ttm)
6.38M
Revenue Growth
+36.96%
P/S Ratio
0.04
Revenue / Employee
6.38M
Employees
1
Market Cap
281.17K
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.10M | 992.82K | 24.17% |
| Dec 31, 2024 | 4.11M | 1.70M | 70.44% |
| Dec 31, 2023 | 2.41M | 879.73K | 57.49% |
| Dec 31, 2022 | 1.53M | 1.09M | 249.46% |
| Dec 31, 2021 | 437.89K | 382.81K | 694.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRegenerative Medical Technology Group News
- 16 days ago - RMTG Launches ISSCA AI(TM) Clinical Intelligence Platform, Extending Its Global Regenerative Medicine Network Into AI-Driven Clinical Infrastructure - Accesswire
- 22 days ago - Global Stem Cells Group (OTC:RMTG) Launches ISSCA Mobile App, Advancing Its Buildout of a Global Digital Ecosystem for Regenerative Medicine - Accesswire
- 4 weeks ago - RMTG Surges 93% in Revenue, 87% in Gross Profit and 70% in Operating Income for Q1 2026 vs Q1 2025 - Accesswire
- 3 months ago - RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind - Accesswire
- 8 months ago - RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit - Accesswire
- 9 months ago - RMTG Subsidiary CELLGENIC Expands into Dominican Republic with New Distribution Partnership - Accesswire
- 9 months ago - RMTG Expands into Brazil with Strategic Representation Agreement - Accesswire
- 9 months ago - RMTG's ISSCA Regenerative Medicine Global Summit 2025 Concludes in Cancún with Full Attendance from 30+ Countries - Accesswire